Tronox Limited (TROX) Shares Rose While Private Capital Management Lowered Stake; Westchester Capital Management Upped Its Pfizer (PFE) Stake by $685,146

December 7, 2017 - By Linda Rogers

Private Capital Management Llc decreased its stake in Tronox Limited (TROX) by 1.06% based on its latest 2017Q2 regulatory filing with the SEC. Private Capital Management Llc sold 20,842 shares as the company’s stock rose 28.57% with the market. The institutional investor held 1.95 million shares of the major chemicals company at the end of 2017Q2, valued at $29.49M, down from 1.97M at the end of the previous reported quarter. Private Capital Management Llc who had been investing in Tronox Limited for a number of months, seems to be less bullish one the $2.23B market cap company. The stock decreased 27.03% or $6.9 during the last trading session, reaching $18.63. About 13.18M shares traded or 573.17% up from the average. Tronox Limited (NYSE:TROX) has risen 311.09% since December 7, 2016 and is uptrending. It has outperformed by 294.39% the S&P500.




Westchester Capital Management Inc increased its stake in Pfizer Inc. (PFE) by 11.57% based on its latest 2017Q2 regulatory filing with the SEC. Westchester Capital Management Inc bought 20,762 shares as the company’s stock declined 3.45% while stock markets rallied. The institutional investor held 200,269 shares of the health care company at the end of 2017Q2, valued at $6.73M, up from 179,507 at the end of the previous reported quarter. Westchester Capital Management Inc who had been investing in Pfizer Inc. for a number of months, seems to be bullish on the $211.96 billion market cap company. The stock decreased 0.20% or $0.07 during the last trading session, reaching $35.56. About 17.38M shares traded or 6.54% up from the average. Pfizer Inc. (NYSE:PFE) has declined 2.76% since December 7, 2016 and is downtrending. It has underperformed by 19.46% the S&P500.

Among 21 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 11 Hold. Therefore 43% are positive. Pfizer had 66 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Piper Jaffray with “Buy” on Friday, August 14. As per Wednesday, November 2, the company rating was downgraded by Argus Research. Barclays Capital initiated Pfizer Inc. (NYSE:PFE) on Tuesday, December 1 with “Equal-Weight” rating. BMO Capital Markets maintained the stock with “Buy” rating in Tuesday, September 5 report. On Tuesday, August 1 the stock rating was maintained by BMO Capital Markets with “Hold”. The rating was downgraded by Credit Suisse to “Neutral” on Thursday, July 20. Credit Suisse maintained the shares of PFE in report on Monday, May 9 with “Outperform” rating. The stock of Pfizer Inc. (NYSE:PFE) earned “Outperform” rating by Cowen & Co on Tuesday, October 20. The rating was maintained by Jefferies on Thursday, July 13 with “Hold”. Morgan Stanley upgraded it to “Overweight” rating and $38 target in Friday, October 2 report.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Fool.com which released: “Better Buy: Novavax, Inc. vs. Pfizer Inc.” on November 07, 2017, also Livetradingnews.com with their article: “Pfizer Inc (NYSE:PFE) Heffx Technical Analysis” published on December 05, 2017, Investorplace.com published: “Why It’s Time to Put Pfizer Inc. Stock on Your Watchlist” on November 17, 2017. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Nasdaq.com and their article: “Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for November 09, 2017” published on November 08, 2017 as well as Mlive.com‘s news article titled: “Pfizer Inc. is looking to fill 200 new positions in Portage” with publication date: November 13, 2017.

Investors sentiment decreased to 0.94 in 2017 Q2. Its down 0.01, from 0.95 in 2017Q1. It is negative, as 58 investors sold PFE shares while 716 reduced holdings. 112 funds opened positions while 612 raised stakes. 4.02 billion shares or 1.07% less from 4.06 billion shares in 2017Q1 were reported. Leavell Mgmt Incorporated reported 138,331 shares. Inv Ptnrs Oh Adv stated it has 40,639 shares or 1.24% of all its holdings. Bailard, California-based fund reported 23,981 shares. Hyman Charles D owns 121,233 shares. Family reported 10,550 shares or 0.24% of all its holdings. Fairfax Can stated it has 0.62% in Pfizer Inc. (NYSE:PFE). Welch And Forbes holds 0.95% or 1.01M shares in its portfolio. Cleararc Capital reported 175,405 shares. London Of Virginia reported 1.59% stake. Autus Asset Management Lc holds 0.05% or 6,681 shares. Ativo, Illinois-based fund reported 61,370 shares. 135,518 were accumulated by Burney Co. Main Street Rech Ltd Limited Liability Company holds 0.13% or 23,819 shares in its portfolio. Woodstock holds 153,625 shares or 1.01% of its portfolio. Salem Investment Counselors holds 1.2% of its portfolio in Pfizer Inc. (NYSE:PFE) for 307,402 shares.

More important recent Tronox Limited (NYSE:TROX) news were published by: Prnewswire.com which released: “Tronox To Vigorously Fight FTC Lawsuit” on December 06, 2017, also Nasdaq.com published article titled: “Tronox Enters Oversold Territory (TROX)”, Reuters.com published: “BRIEF-Tronox Ltd names Jeffry Quinn as CEO” on November 16, 2017. More interesting news about Tronox Limited (NYSE:TROX) was released by: Nasdaq.com and their article: “Tronox Limited (TROX) Ex-Dividend Date Scheduled for November 17, 2017” with publication date: November 16, 2017.

Investors sentiment increased to 1.08 in Q2 2017. Its up 0.04, from 1.04 in 2017Q1. It is positive, as 22 investors sold TROX shares while 44 reduced holdings. 28 funds opened positions while 43 raised stakes. 59.37 million shares or 4.43% more from 56.85 million shares in 2017Q1 were reported. Manufacturers Life The reported 48,279 shares. Quantbot Technologies Ltd Partnership has 0.09% invested in Tronox Limited (NYSE:TROX). Thompson Davis Inc invested 0.01% in Tronox Limited (NYSE:TROX). Peak6 Ltd Partnership, a Illinois-based fund reported 16,305 shares. Aristeia Cap Limited Liability Com holds 0.21% or 276,674 shares. Victory Management reported 2.85M shares. Int Group invested in 0% or 40,341 shares. Strs Ohio invested in 800 shares. Northern Trust reported 749,160 shares stake. Hennessy Advisors owns 267,800 shares. Teachers Insurance And Annuity Association Of America reported 0.13% stake. State Street Corporation reported 1.28 million shares or 0% of all its holdings. Lucus Advisors Ltd Co has invested 0.53% in Tronox Limited (NYSE:TROX). Moreover, Laurion Management Lp has 0% invested in Tronox Limited (NYSE:TROX) for 11,200 shares. Frontier Cap Management Communication Ltd Com invested in 0.17% or 1.54 million shares.

Among 6 analysts covering Tronox (NYSE:TROX), 5 have Buy rating, 1 Sell and 0 Hold. Therefore 83% are positive. Tronox had 15 analyst reports since August 6, 2015 according to SRatingsIntel. As per Monday, July 31, the company rating was maintained by Alembic. Alembic maintained the shares of TROX in report on Monday, June 26 with “Buy” rating. The rating was maintained by UBS with “Sell” on Friday, October 13. Alembic maintained the stock with “Buy” rating in Tuesday, August 8 report. The rating was initiated by J.P. Morgan on Tuesday, October 24 with “Buy”. The firm has “Sell” rating by UBS given on Thursday, August 4. B. Riley & Co downgraded the stock to “Neutral” rating in Thursday, August 6 report. The firm has “Buy” rating by Alembic given on Monday, October 23. The company was maintained on Thursday, August 13 by RBC Capital Markets. UBS maintained Tronox Limited (NYSE:TROX) rating on Thursday, November 9. UBS has “Sell” rating and $18 target.

Analysts await Tronox Limited (NYSE:TROX) to report earnings on February, 20. They expect $-0.03 EPS, up 78.57% or $0.11 from last year’s $-0.14 per share. After $0.08 actual EPS reported by Tronox Limited for the previous quarter, Wall Street now forecasts -137.50% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.